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Porcine reproductive and respiratory syndrome virus (PRRSV) infection results in extensive tissue
inﬂammation and damage, which are believed to be responsible for increased susceptibility to secondary
infection and even for death. However, its pathogenic mechanisms are not fully understood. To explore
the mechanism underlying the PRRSV-induced tissue inﬂammation and damage, we investigated
whether PRRSV activates porcine alveolar macrophage (PAM) inﬂammasomes which mediate por-IL-1β
maturation/release and subsequently induce tissue inﬂammation and injury. Our results showed that
PRRSV and its small envelope protein E signiﬁcantly increased IL-1β release from LPS-primed PAMs;
however, only PRRSV not protein E signiﬁcantly increased IL-1β release from no-LPS-primed PAMs, which
indicates PRRSV can activate inﬂammasomes of PAMs by its encoded protein E. These results provide a
molecular basis for the pathogenic mechanism of PRRSV on inducing extensive tissue inﬂammation and
damage, and suggest that the inﬂammasome may provide a potential therapeutic target for PRRS
prevention and treatment.
& 2013 Elsevier Inc. All rights reserved.Introduction
Porcine reproductive and respiratory syndrome (PRRS), caused
by PRRS virus (PRRSV), is an acute infectious disease threatening
swine production worldwide, characterized by the late-term
reproductive failure in pregnant sows and respiratory disorder in
piglets and young pigs (Lunney et al., 2010). So far, PRRS has not
been effectively controlled.
Since its emergence in the late 1980s, many researches on PRRS
etiology, epidemiology, pathogenic mechanisms, diagnosis and
prevention have been extensively conducted (Nelsen et al., 1999;
Meng et al., 1995; Hermann et al., 2007; Prickett et al., 2008b;
Calzada-Nova et al., 2012)
Particularly, the pathogenic mechanisms based on virus–host
interactions such as PRRSV antibody-dependent enhancement and
immune suppression (Cancel-Tirado et al., 2004; Qiao et al., 2011)
has been especially concerned. As we known, PRRSV mainlyll rights reserved.
izhong2000@yahoo.
aper.infects porcine macrophages, especially alveolar macrophages
(PAMs) (An et al., 2010). Upon PRRSV infection, the PAMs are
activated and induce the extensive inﬂammatory reactions and
damage in PRRSV-infected tissues such as lungs and placenta
(Thanawongnuwech et al., 2004), which are believed to be the
most important pathogenic events leading to increase of suscept-
ibility to secondary infection and even to death. Nevertheless, the
mechanism by which PRRSV initiates PAM-activated inﬂammation
is unknown. Recent studies, however, have revealed that
macrophage-mediated tissue inﬂammation is related to a multi-
protein complex called the inﬂammasome (Rathinam et al., 2012;
McIntire et al., 2009; Kanneganti, 2010), which initiates innate
immune responses by activation of caspase-1 protease, which
processes pro-interleukin-1β (pro-IL-1β) and pro-interleukin-18
(pro-IL-18), removing the amino-terminal amino acids to release
mature and active forms of the cytokines, the most signiﬁcant
inﬂammatory cytokines in triggering tissue inﬂammation
(Dinarello et al., 2012).
The inﬂammasome, a multiprotein oligomer, consists mainly of
caspase 1, apoptosis-associated speck-like protein containing
CARD (ASC) and Nod-like receptors (NLRs) such as NLRP1, NLRP3,
NLRC4, NLRP6 and NLRP12. NLRs constitute a family of
K. Zhang et al. / Virology 442 (2013) 156–162 157intracellular pattern recognition receptors (PRRs) in monocytes/
macrophages, which sense microbial molecules and endogenous
“danger” signals released by injured cells.
Synthesis and processing of IL-1β are considered to require two
distinct signals. One is the signal 1 involved in nuclear factor κB
(NF-κB) activation leading to pro-IL-1β synthesis, triggered by
various pathogen-associated molecular patterns (PAMPs) through
pattern recognition receptors (PRRs) such as toll-like receptor
(TLR) and retinoic acid-inducible gene 1 (RIG-I)-like receptors
(RLRs). For example, lipopolysaccharide (LPS) can activate NF-κB
through TLR4. Another is the signal 2 associated with inﬂamma-
some activation resulting in IL-1β and IL-18 processing and release,
triggered by the conserved motifs of pathogens or cell danger
signals following inﬂammasome/caspase-1 activation.
Whether or not PRRSV activates inﬂammasomes in macro-
phages and initiates extensive inﬂammatory reaction in virus-
infected tissues has, until now, not been established. The work
presented here provides evidence that this mechanism is opera-
tive through PRRSV-encoded protein E.0
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Fig. 1. PRRSV activation of inﬂammasomes of porcine alveolar macrophages. (A) Surviva
infection at the different MOI on IL-1β release from macrophages. (LPS+ATP group is a p
1 in PRRSV-infected PAMs. (D∼F) Effect of zYVAD-FMK on IL-1β, TNFα and IL-6 release f
PRRSV-infected PAMs detected by RT-PCR.Results
PRRSV activates the inﬂammasomes of PAMs
To determine whether PRRSV activates the inﬂammasomes of
PAMs, the PAMs were pre-treated with or without LPS and then
infected with PRRSV (North American genotype PRRSV generated
from the infectious clone pFL12) at different multiplicities of
infection (MOI), the cell survival rates (Fig. 1A) at different time
points postinfection were estimated by trypan blue exclusion, the
IL-1β concentrations in the cell culture were measured by ELISA
and caspase 1 in PAMs were detected byWestern blot at 72 h post-
infection. The Results showed that the cell survival rates decreased
with the increase of the MOI and duration of PRRSV infection. The
IL-1β concentration in the medium of LPS-primed or unprimed
PAMs signiﬁcantly increased proportionately with an increase in
MOI (Po0.05∼0.01) (Fig. 1B). Moreover, the IL-1β levels in the
medium of LPS-primed PAMs was signiﬁcantly higher than un-
primed PAMs (Po0.01). This suggests that PRRSV promotesAT
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K. Zhang et al. / Virology 442 (2013) 156–162158cytokine release by activating two signals, the NF-κB signal for
pro-IL-1β synthesis and the inﬂammasome signal for IL-1β proces-
sing and release. The Western blot in Fig. 1C showed that PRRSV
induced the cleavage of pro-caspase 1 (45 kDa) to generate mature
caspase 1 (10 kDa) either LPS-primed or unprimed PAMs, but
higher level of the mature caspase 1 was detected in LPS-primed
PAMs compared with unprimed cells (Fig. 1C), which corresponds
to the variation of IL-1β in the medium. Taking together, the results
demonstrate that PRRSV can activate PAM inﬂammasome signal as
well as NF-kB signal.
To provide further evidence that PRRSV can activate both NF-kB
and inﬂammasome signals, TNFα and IL-6 concentrations in
the media of PRRSV-infected PAMs were analyzed by ELISA, and
the IL-1β and TNFα mRNA levels were estimated by RT-PCR, over
the same period since these two cytokines, together with pro-IL-
1β, are synchronously synthesized in macrophages by NF-κB
signal activation, however, the TNFα and IL-6 are directly released
from the cells without any processing step such as pro-IL-1β
processing by caspase 1. The data in Fig. 1D∼F show that PRRSV
increases IL-1β, TNFα and IL-6 release from either LPS-primed or
unprimed PAMs. LPS signiﬁcantly increased the releases of TNFα
and IL-6 (Fig. 1E and F), but not IL-1β (Fig. 1D). PRRSV also
increased IL-1β and TNFα mRNA levels either in LPS-primed or
unprimed PAMs. Benzyloxycarbonyl–Tyr–Val–Ala–Asp(OMe)–
ﬂuoromethyl-ketone (zYVAD-FMK), a caspase 1 inhibitor, signiﬁ-
cantly inhibited IL-1β release from PRRSV-infected LPS-primed or
unprimed PAMs (Fig. 1D), but did not signiﬁcantly affect TNFα and
IL-6 release (Fig. 1E and F). Therefore, the results future demon-
strate that PRRSV activates both TLR signals and inﬂammasome
signals.94
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Fig. 2. mRNA-mediated PRRSV envelope protein E expression in porcine macrophages. (
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inﬂammasomes
Inﬂammasome activation is closely related to K+ efﬂux and Ca2+
inﬂux (Pétrilli et al., 2007; Lee et al., 2012). Therefore, any
substances that affect these two ion transportations are likely to
inﬂuence their activation. The small envelope protein E of PRRSV
has been reported to be an ion channel-like protein; hence, we
hypothesized that protein E could activate PAM inﬂammasomes to
trigger inﬂammation. To prove the hypothesis, we adopted mRNA-
mediated gene transfection method, an efﬁcient gene transduction
method into monocyte/macrophages (Zhong et al., 2006), to trans-
fect protein E gene into LPS-primed PAMs and analyzed the effects
of protein E on inﬂammasome activation.
To synthesize protein E mRNA, protein E gene was ampliﬁed
from PRRSV infectious clone pLF12. The expression vectors of
protein E gene controlled by CMV/T7 promoters, alone or fused
with a His-tag, were constructed from pcDNA3.1A eukaryotic
expression vector (Fig. 2A). The corresponding protein E mRNA
was synthesized in vitro with a commercial kit (see Materials and
methods). Fig. 2B shows the synthesized protein E mRNA without
and with a poly (A) tail. To detect mRNA-mediated protein E
expression in PAMs, the PAMs were transfected with His-tag-fused
protein E mRNA using Transmessenger Transfection reagents
(Ambion). The protein E was identiﬁed by immuno-blot to be
effectively expressed in PAMs mediated by its mRNA (Fig. 2C).
The mRNA-mediated gfp gene expression in PAMs as control was
observed directly under the ﬂuorescent microscope (Fig. 2D).
To explore the effects of protein E on inﬂammasome activation,
the LPS-primed and unprimed PAMs were transfected with protein955
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K. Zhang et al. / Virology 442 (2013) 156–162 159E mRNA at different doses, and IL-1β release from the PAMs and
caspase 1 cleavage in the PAMs were detected by ELISA and
Western blot, respectively, at 6 h post-transfection. The result in
Fig. 3A shows that protein E signiﬁcantly increased IL-1β release
dose-dependently from LPS-primed PAMs but not from unprimed
PAMs, and moreover, protein E mRNA transfection, not GFP mRNA
(negative control mRNA), induced caspase 1 cleavage into a
mature form (10 kDa). Above results indicate that protein E can
activate PAM inﬂammasomes but not TLRs or other NF-κB signal-
ing pathway. To further conﬁrm the role of protein E in inﬂamma-
some activation, the caspase 1 inhibitor zYVAD-FMK was used to
pre-treated protein E mRNA-transfected LPS-primed PAMs, the IL-
1β and TNFα in the media were measured by ELISA, the data in
Fig. 3B indicate that the release of IL-1β not TNFα from the PAMs
was signiﬁcantly inhibited by zYVAD-FMK treatment. These
experiments provide strong evidence that protein E, unlike intact
PRRSV, activates inﬂammasomes but not NF-κB signaling pathway.
Ion channel blocker inhibits inﬂammasome activation induced by
PRRSV and protein E
PRRSV protein E was considered as an ion channel-like protein
and its activity was blocked by amatadine, an ion channel inhibitor
(Lee and Yoo, 2006), but whether this characteristic is associated
with inﬂammasome activation induced by PRRSV is unclear.
Therefore, we used amantadine to treat LPS-primed PAMs and
then infected the cells with PRRSV and transfected the cells with
protein E mRNA, following which the release of IL-1β was
measured. Fig. 4 shows that release of IL-1β, either from PRRSV-
infected or from protein E mRNA-transfected amantadine-treated
PAMs, was signiﬁcantly decreased in a dose-dependant manner. At
an amantadine dose of 0.5 mM, release of IL-1β dropped sharply,
indicating that the reagent signiﬁcantly inhibited inﬂammasome
activation of PAMs induced by PRRSV or protein E. These results
not only conﬁrm that protein E is an ion channel-like protein, butalso demonstrate that protein E channel activity is associated with
inﬂammasome activation induced by PRRSV.Discussion
Our ﬁndings in this paper have provided a previously unknown
mechanism by which PRRSV-induced inﬂammatory response in
infected tissues is associated with inﬂammasome activation in
PAMs, which are triggered mainly by PRRSV-encoded small
envelope protein E, an ion channel-like protein. We have shown
that PRRSV not only activates inﬂammasomes for IL-1βmaturation
and release but also activates NF-κB for pro-IL-1β expression, since
PRRSV signiﬁcantly promoted IL-1β release from either LPS-
primed or unprimed PAMs. Also, the caspase 1 inhibitor zYVAD-
FMK signiﬁcantly suppressed IL-1β release from PRRSV-infected
K. Zhang et al. / Virology 442 (2013) 156–162160LPS-primed or unprimed PAMs, but did not signiﬁcantly affect
TNFα and IL-6 release.
For pro-IL-1β expression regulation, we supposed that PRRSV
might activate the NF-κB signaling pathway through conserved
pathogen-associated molecular patterns (PAMPs) of PRRSV, such
as PRRSV dsRNA and ssRNA, to prime the corresponding pattern
recognition receptors (PRRs) in the macrophage membrane and
cytosol. It is well known that membrane-bound TLR3 and TLR7 can
sense extracellular viral dsRNA and ssRNA, respectively (Botos et
al., 2009; Bowie and Unterholzner, 2008) while cytosolic PRRs,
including RLRs and melanoma differentiation-associated gene-5
(MDA5), can recognize intracellular viral ssRNA and dsRNA (Kato
et al., 2006). Upon priming by PRRSV RNAs, both membrane-
bound and cytosolic PRRs would be activated and consequently
activate the NF-κB pathway to promote expression of pro-
inﬂammatory cytokines such as TNFα, IL-6 and pro-LI-1β. In
addition to PRRSV RNAs, other components of PRRSV, such as
protein N (Luo et al., 2011), might also activate this pathway and
enhance pro-inﬂammatory cytokine production.
Maturation of IL-1β has recently been identiﬁed as being
associated with activation of inﬂammasomes (Martinon et al.,
2002). Many such factors involved in inﬂammasome activation
have been identiﬁed, including pathogen derived molecules (DNA,
RNA, pore-forming toxin, ﬂagellin, viral channel-like protein) (Kato
et al., 2006; Gurcel et al., 2006; Zhao et al., 2011; Ichinohe et al.,
2010), crystals/particles (silica, asbestos, urates and cholesterol)
(Hornung et al., 2008; Dostert et al., 2008; Denoble et al., 2011;
Duewell et al., 2010) and endogenous danger molecules such as
ATP (Piccini et al., 2008) and reactive oxygen species (ROS)
(Sorbara and Girardin, 2011). Our results have shown that PRRSV
protein E activates PAM inﬂammasomes, which suggests that
protein E is the main contributory factor for PRRSV-induced
inﬂammasome activation and the resulting robust IL-1β produc-
tion might be the main reason for eliciting the strong inﬂamma-
tory response and damage of PRRSV-infected tissue. Undoubtedly
other factors, either from PRRSV-derived molecules (RNA, other
structural proteins and non-structural proteins) or PRRSV-
infection-induced molecules of host cells, such as ATP released
from PRRSV-infected dying cells and ROS generated in the PRRSV-
infected cells, might also contribute to, and amplify, inﬂamma-
some activation.
Protein E has been identiﬁed to be an ion channel-like protein
associated with uncoating and viral genome delivery into the
cytoplasm, and therefore is essential for PRRSV infection and
replication (Lee and Yoo, 2006). However, the molecular mechan-
ism underlying inﬂammasome activation by protein E remains
unknown. Ion channel protein-induced inﬂammasome activation
has been shown to be related to the disturbance of ion home-
ostasis, especially K+ and Ca2+. K+ efﬂux is a well-known activator
of NLRP3 inﬂammasomes (Pétrilli et al. 2007) and recent reports
have shown that Ca2+ inﬂux is also an important activator (Zhong,
et al., 2013; Lee et al., 2012). To investigate whether protein E-
induced inﬂammasome activation is associated with its ion chan-
nel characteristics, we referred to Lee's experimental result
(amantadine blocks protein E function) (Lee and Yoo, 2006) and
used amantadine to inhibit protein E-induced inﬂammasome
activation. As expected, amantadine signiﬁcantly inhibited PRRSV-
and protein E-induced inﬂammasome activation. These results
indicate that protein E-induced inﬂammasome activation is asso-
ciated with protein E ion channel characteristics.
Our data have also shown that the pathogenic role of the viral
ion channel protein is associated with inﬂammasome activation.
Blocking the viral channel might not only disrupt the viral life
cycle but also inhibit inﬂammasome-mediated tissue inﬂamma-
tion and injury. Therefore, anti-inﬂammasome therapy might
provide a potential target for PRRS prevention and treatment.In this study, we have focused on the role of PRRSV protein E in
inﬂammasome activation, but whether or not other PRRSV-
encoded proteins are involved in inﬂammasome activation
remains undetermined. Additionally, inﬂammasome activation
pathways include many proteins and receptors, but it is unknown
which of these are involved in PRRSV- and protein E-induced
inﬂammasome activation. All the above aspects remain to be
further investigated.Materials and methods
Cells, viruses, plasmids, and reagents
MARC 145, BHK-21 and HEK293T cells were purchased from the
Chinese Academy of Medical Sciences, and cultured in Dulbecco's
modiﬁed Eagle's medium (DMEM) supplemented with 10% (v/v)
fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin,
2 mM L-glutamine (DMEM complete medium) at 37 1C and 5% CO2.
PAMs, isolated from piglets as described previously (Zhang et al.,
2012), were cultured in RPMI-1640 medium supplemented as in
the DMEM-based medium described above. PRRS virus, a North
American genotype strain, was generated from PRRSV infectious
clone pFL12 plasmid containing the North American genotype
PRRSV strain genome (Truong et al., 2004). pcDNA3.1/gfp plasmid,
a expression vector for green ﬂuorescent protein, was constructed
in our laboratory previously (Zhong et al., 2006). Amantadine,
zYVAD-FMK and LPS were from Sigma. Pme I restriction enzyme
and Low Range ssRNA Markers were from New England Biolabs,
Immun-Star™ substrate pack from Bio-Rad.
Ampliﬁcation of protein E gene and construction of its eukaryotic
expression vectors
PRRSV small envelope protein E genes with or without a stop
codon were ampliﬁed from plasmid pFL12 containing the PRRSV
complete genome using the following primer pairs: E protein with
stop codon, 5′–CGGGGTACC(KpnI)GCCAC CATGGGGTCCATGCAA-
AGCC–3′ (forward) and 5´–CGGACCGGT(AgeI) TCATA GGATCTTCTG-
TAATTGC–3′ (reverse); E protein without stop codon, 5′–CGGG
GTACC(KpnI)GCCACCATGGGGTCCATGCAAAGCC-3´ (forward) and
5′CGGA CCGGT(AgeI)ACATAGGATCTTCTGTAATTGC–3′ (reverse).
The E protein genes with stop codon and without stop codon
were subcloned into pcDNA3.1A to construct non-fused and His-
tag-fused E protein gene expression vectors pcDNA-PRRSV-E and
pcDNA-PRRSV-E/H, respectively (Fig. 2A), in which the E protein
genes were driven by the CMV/T7 promoter.
Synthesis of protein E mRNA in vitro
Synthesis of protein E mRNA and GFP mRNA as a control were
performed in vitro with mMESSAGE mMACHINE High Yield
Capped RNA Transcript Kit (Ambion) according to the manufac-
turer's instructions. Brieﬂy, the pcDNA-PRRSV-E, pcDNA-PRRSV-
E/H and pcDNA3.1/gfp vectors were ﬁrst linearized by Pme
I digestion at the site downstream of the His-tag. Then, the
5′-end capped mRNA was transcribed by T7 RNA polymerase
in vitro using the linearized plasmid as a template and Cap/NTPs
as substrates. Finally, poly (A) tail was added at the 3′-end of the
capped mRNA by Yeast poly (A) polymerase (United States
Biochemical) to generate 5′-end capped and 3′-end tailed protein
E mRNA. The size and the concentration of the protein E mRNA
and GFP mRNA were measured by denaturing agarose gel electro-
phoresis and NanoDrop 2000 (Thermo Science) spectrophotome-
try, respectively.
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Generation of PRRSV from infectious cDNA clone was per-
formed as previously described (Truong et al., 2004). Brieﬂy, the
pFL12 plasmid was linearized by Acl I enzyme. The PRRSV genomic
mRNA with 5′-end cap and 3′-end poly (A) tail was synthesized
using the same method as described above for the protein E mRNA
preparation. BHK-21 cells were transfected with PRRSV genomic
mRNA mediated with Transmessenger Transfection reagents. The
cells were cultured at 37 1C in a 5% CO2 atmosphere. The cells were
harvested at 48 h post-transfection and ruptured by 3 freeze/thaw
cycles. After centrifugation, the supernatants containing rescued
PRRSV were used to infect MARC 145 cells for PRRSV ampliﬁcation.
Following appearance of speciﬁc PRRSV cytopathic effects, the
cells were harvested and frozen at −20 1C until required.
Stimulation of PAMs by LPS
PAMs were cultured in RPMI 1640 medium supplemented with
10% fetal calf serum (FBS) at 37 1C in a 5% CO2 atmosphere. At 90%
conﬂuence, adherent cells were trypsinized and added to 24-well
plates in X-VIVO-15 serum-free medium (Lonza Bioscience) at a
density of 2105 cells/ml. Following stimulation with LPS (100 μg/
ml) for 12 h, the PAMs were ready for PRRSV infection or protein E
mRNA transfection.
PRRSV infection and protein E mRNA transfection of LPS-primed PAMs
LPS-primed PAMs were infected with PRRSV at different multi-
plicities of infection (MOI¼1, 2, 4, 8) or transfected with protein E
mRNA mediated by Transmessenger Transfection reagent at dif-
ferent doses (0.5, 1, 2 μg). The cell culture media were collected at
72 h post-infection or at 4 h post-transfection. Untreated LPS-
primed PAMs were incubated with ATP (5 mM) for 3 h as a
positive control for inﬂammasome activation.
Cytokine assay
Concentration of porcine IL-1β, TNFα and IL-6 in the culture
media were measured by double antibody sandwich ELISA using
RayBiotech Porcine IL-1β ELISA kit, RayBiotech Porcine TNF-alpha
ELISA Kit and RayBiotech Porcine IL-1β ELISA kit (RayBiotech),
respectively, according to the manufacturer's protocols.
Ampliﬁcation of PRRSV and virus titer determination
PRRSV were ampliﬁed in MARC 145 cells and the virus titers
determined by TCID50.
RT-PCR assay
Total RNA from PAMs was isolated with RNeasy Kit (Qiagen) and
reverse transcribed with High-capacity cDNA Reverse Transcription
Kit (Applied Biosystems). The generated cDNA was ampliﬁed by PCR
using Taq DNA polymerase (Promega) with special primers designed
using DNASTAR Lasergene software: IL-1β, 5′–TGTCATCGTGGCAGTG-
GAG–3′ (forward) and 5′–CAGGGTGGGCGTGTTAT CTTTC–3′ (reverse);
TNFα, 5′–GGTTATCGGCCCCCAGAAGGA–3′ (forward) and 5′–TAGGA-
GACGGCGATGCGGCTG–3′ (reverse); GAPDH (glyceraldehyde-3-phos-
phate dehydrogenase as a control), 5′–ATCCCGCCAACATCAAAT–3′
(forward) and 5′–GCAGCGCCGGTAGAAGC–3′ (reverse).
Western blot
Recombinant protein E expression in PAMs was detected by
Western blot. Brieﬂy, the PAMs in 6-well plates were transfectedwith the His-tag-fused protein E mRNA (6 μg) synthesized in vitro.
The cells were lysed at 3 h after transfection with lysis buffer
(5 mM Tris-HCl, 25 mM KCl, 2 mM EGTA, 2 mM EDTA, 1% NP-40,
150 mM NaCl, protease inhibitor cocktail, pH 7.4). The lysates were
centrifuged and the supernatant fractions were collected for
Western blot assay. Cell lysis samples were subjected to 15%
SDS-PAGE, and separated proteins were transferred onto nitrocel-
lulose membranes by electro-blotting. Recombinant protein E fused
with His-tag was detected with mouse anti-His tag monoclonal
antibody and alkaline phosphatase-conjugated goat anti-mouse IgG
(Santa cruz). Blots were developed using the Immun-StarTM
(Bio-Rad) substrate pack. Pro-caspase 1 (p45) in PAMs and mature
caspase 1 (p10) in PAMs and the media were detected with rabbit
anti-human caspase 1 p10 antibody (cross-reaction with porcine
caspase 1) and alkaline phosphatase-conjugated goat anti-rabbit
IgG (Santa cruz) using the same protocol described above.
Statistical analysis
Data were analyzed with SPSS 18.0 and the statistically sig-
niﬁcant differences were determined by Student's t test.Acknowledgments
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